BioVie Statistics
Total Valuation
BioVie has a market cap or net worth of $9.88 million. The enterprise value is -$3.08 million.
Important Dates
The next estimated earnings date is Tuesday, May 26, 2026, after market close.
| Earnings Date | May 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BioVie has 7.54 million shares outstanding. The number of shares has increased by 415.78% in one year.
| Current Share Class | 7.54M |
| Shares Outstanding | 7.54M |
| Shares Change (YoY) | +415.78% |
| Shares Change (QoQ) | +51.90% |
| Owned by Insiders (%) | 0.53% |
| Owned by Institutions (%) | 15.55% |
| Float | 7.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.64 |
| P/TBV Ratio | 0.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.97, with a Debt / Equity ratio of 0.02.
| Current Ratio | 9.97 |
| Quick Ratio | 9.02 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1,088.49 |
Financial Efficiency
Return on equity (ROE) is -106.43% and return on invested capital (ROIC) is -67.59%.
| Return on Equity (ROE) | -106.43% |
| Return on Assets (ROA) | -61.04% |
| Return on Invested Capital (ROIC) | -67.59% |
| Return on Capital Employed (ROCE) | -130.18% |
| Weighted Average Cost of Capital (WACC) | 8.13% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.54M |
| Employee Count | 13 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.61% in the last 52 weeks. The beta is 0.72, so BioVie's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | -88.61% |
| 50-Day Moving Average | 1.45 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 36.99 |
| Average Volume (20 Days) | 107,760 |
Short Selling Information
The latest short interest is 129,231, so 1.71% of the outstanding shares have been sold short.
| Short Interest | 129,231 |
| Short Previous Month | 154,206 |
| Short % of Shares Out | 1.71% |
| Short % of Float | 1.72% |
| Short Ratio (days to cover) | 2.01 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -20.60M |
| Pretax Income | -19.92M |
| Net Income | -19.96M |
| EBITDA | -20.37M |
| EBIT | -20.60M |
| Earnings Per Share (EPS) | -$3.49 |
Full Income StatementBalance Sheet
The company has $13.10 million in cash and $295,717 in debt, with a net cash position of $12.80 million or $1.70 per share.
| Cash & Cash Equivalents | 13.10M |
| Total Debt | 295,717 |
| Net Cash | 12.80M |
| Net Cash Per Share | $1.70 |
| Equity (Book Value) | 15.61M |
| Book Value Per Share | 2.07 |
| Working Capital | 15.19M |
Full Balance SheetCash Flow
| Operating Cash Flow | -20.51M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 229,377 |
| Net Borrowing | 2.90M |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
